Beranger N - Search Results

1

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.

Delrue M, Siguret V, Neuwirth M, Joly B, Beranger N, Sène D, Chousterman BG, Voicu S, Bonnin P, Mégarbane B, Stépanian A. Delrue M, et al. Among authors: beranger n. Br J Haematol. 2021 Mar;192(6):1097-1100. doi: 10.1111/bjh.17216. Epub 2020 Dec 24. Br J Haematol. 2021. PMID: 33368196 Free article. No abstract available.

2

Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.

Lefrère B, Stepanian A, Charles P, Foulon-Pinto G, Béranger N, Alhenc-Gelas M, Drouet L, Siguret V. Lefrère B, et al. Among authors: beranger n. Thromb Res. 2019 Jun;178:75-78. doi: 10.1016/j.thromres.2019.04.010. Epub 2019 Apr 9. Thromb Res. 2019. PMID: 30991241 Review. No abstract available.

3

Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.

Béranger N, Benghezal S, Savigny S, Capdenat S, Joly BS, Coppo P, Stepanian A, Veyradier A. Béranger N, et al. Thromb Res. 2019 Sep;181:29-35. doi: 10.1016/j.thromres.2019.07.012. Epub 2019 Jul 16. Thromb Res. 2019. PMID: 31330376

4

Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay.

Beranger N, Benghezal S, Joly BS, Capdenat S, Delton A, Stepanian A, Coppo P, Veyradier A. Beranger N, et al. Res Pract Thromb Haemost. 2020 Dec 15;5(1):81-93. doi: 10.1002/rth2.12461. eCollection 2021 Jan. Res Pract Thromb Haemost. 2020. PMID: 33537532 Free PMC article.

5

[Acquired hemophilia A: clinical and biological characteristics and therapeutic management of a series of eight patients hospitalized in Lariboisière and Saint-Louis hospitals].

Noizat C, Béranger N, Joly BS, Veyradier A, Stepanian A, Siguret V, Itzhar-Baïkian N. Noizat C, et al. Among authors: beranger n. Ann Biol Clin (Paris). 2021 Feb 1;79(1):75-82. doi: 10.1684/abc.2021.1625. Ann Biol Clin (Paris). 2021. PMID: 33622662 Free article. French.

6

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.

Joly BS, Darmon M, Dekimpe C, Dupont T, Dumas G, Yvin E, Beranger N, Vanhoorelbeke K, Azoulay E, Veyradier A. Joly BS, et al. Among authors: beranger n. J Thromb Haemost. 2021 Sep;19(9):2193-2198. doi: 10.1111/jth.15445. Epub 2021 Jul 27. J Thromb Haemost. 2021. PMID: 34219357 Free PMC article.

7

[Lupus anticoagulant and ischemic strokes: about two case reports].

Hilaire J, Noizat C, Duong MT, Delrue M, Hervé D, Stepanian A, Neuwirth M, Hadj-Ali A, Joly BS, Veyradier A, Siguret V, Béranger N. Hilaire J, et al. Among authors: beranger n. Ann Biol Clin (Paris). 2021 Aug 1;79(4):361-367. doi: 10.1684/abc.2021.1662. Ann Biol Clin (Paris). 2021. PMID: 34427558 French.

8

TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Graça NAG, Joly BS, Voorberg J, Vanhoorelbeke K, Béranger N, Veyradier A, Coppo P. Graça NAG, et al. Among authors: beranger n. Br J Haematol. 2022 Apr;197(2):156-170. doi: 10.1111/bjh.18040. Epub 2022 Feb 10. Br J Haematol. 2022. PMID: 35146746 Free PMC article. Review.

9

High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura.

Béranger N, Tsatsaris V, Coppo P, Veyradier A, Joly BS. Béranger N, et al. Hypertension. 2023 Sep;80(9):e140-e142. doi: 10.1161/HYPERTENSIONAHA.123.20987. Epub 2023 May 12. Hypertension. 2023. PMID: 37170814 No abstract available.

10

Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience.

Béranger N, Coppo P, Tsatsaris V, Boisseau P, Provôt F, Delmas Y, Poullin P, Vanhoorelbeke K, Veyradier A, Joly BS. Béranger N, et al. Blood Adv. 2024 Jan 9;8(1):183-193. doi: 10.1182/bloodadvances.2023011972. Blood Adv. 2024. PMID: 38039511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page